# Evaluation of the Safety and Performance Characteristics of Mesofiller Aox for the Correction of Mild and Moderate Facial Wrinkles.

> **NCT06486740** · NA · COMPLETED · sponsor: **Mesoestetic Pharma Group S.L.** · enrollment: 55 (actual)

## Conditions studied

- Skin Aging
- Skin Wrinkling

## Interventions

- **DEVICE:** mesofiller aox

## Key facts

- **NCT ID:** NCT06486740
- **Lead sponsor:** Mesoestetic Pharma Group S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-03
- **Primary completion:** 2024-01-08
- **Final completion:** 2024-01-08
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06486740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06486740, "Evaluation of the Safety and Performance Characteristics of Mesofiller Aox for the Correction of Mild and Moderate Facial Wrinkles.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06486740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*